Biologics Market Transparency Act of 2022
This bill requires biologics manufacturers to notify the Food and Drug Administration in advance of withdrawing a product from sale.
| Action Date | Type | Text | Source |
|---|---|---|---|
| 2022-03-10 | Committee | Referred to the Subcommittee on Health. | House committee actions |
| 2022-03-09 | IntroReferral | Referred to the House Committee on Energy and Commerce. | House floor actions |
| 2022-03-09 | IntroReferral | Introduced in House | Library of Congress |